cannabis tinctures, synthetic cannabinoids), nicotine (tobacco cigarettes, electronic cigarettes, smokeless tobacco, cigars, hookah, tobacco pipe, nicotine replacement), cocaine or crack cocaine, cathinones, methamphetamine, MDMA (ecstasy), ketamine, gamma hydroxybutyrate, heroin, hallucinogens (lysergic acid diethylamide, phencyclidine, peyote, mescaline, N-dimethyltryptamine, alpha-methyltryptamine, or 5-methoxy-N,N-diisopropyltryptamine), psilocybin, salvia, anabolic steroids, inhalants, prescription stimulants, prescription sedatives, prescription opioids, and OTC cough or cold medicine. Harmonization note: instruments overlap with the * National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Study (http://ncanda.org/) (Brown et al., 2015), +Monitoring the Future (MTF) Study (http://www.monitoringthefuture.org/) (Institute for Social Research and U.o.M. Monitoring the Future, 2010) and ^ Population Assessment of Tobacco and Health (PATH) Study (https://pathstudyinfo.nih.gov/UI/HomeMobile.aspx) (Hyland et al., 2016).
